Purchase Order 75N93023P00794

Award Date 6/15/23
Potential Completion Date 9/30/23
Potential Value $249K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases (NIH NIAID) awarded a $683,400.00 firm fixed price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of TURBO293 transfection reagents, kits, protocols, and continuity support. The contract, which did not involve set-asides or subcontractors, was sole-sourced to Speed Biosystems as the proprietary...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business. The $146,788.00 contract is for the provision of TURBO293 transfection reagents, kits, protocols, and continuity support to aid coronavirus-related research at NIH labs and the Vaccine Research Center. The contract has a...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $123,192.00 firm fixed price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business. The contract is for the provision of TURBO293 transfection reagents, kits, protocols, and continuity support to aid coronavirus-related research at NIH labs and the Vaccine Research Center. This sole-source award was made under the...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order to Speed Biosystems, LLC for the provision of COVID-19 TURBO 293 transfection reagents. The contract, valued at $148,325.00, has a period of performance through June 8, 2023. Speed Biosystems is a minority-owned, small disadvantaged business that has previously received over $3 million in prime federal contracts...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of TURBO293 AB Transfection Kit (for 20L culture) and TURBO293 Transfection Reagent (20ml). The $197,020.00 award did not involve any set-aside programs and is intended to support coronavirus-related research at NIH labs and the...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business, to provide 70 units of TURBO293 transfection reagent at a potential value of $146,750.00. The contract supports COVID-19 research and vaccine production activities at NIH labs in Maryland. This sole-source award was made under the...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of TURBO293 transfection reagents to support coronavirus-related research. The contract, valued at $148,325.00, does not have a set-aside designation. Speed Biosystems has received over $3 million in prime federal contracts from...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $222,712.50 firm fixed price purchase order to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of 75 units of TURBO293 Transfection Reagent (20ML), catalog #PXX1002. This sole-source award was made on July 25, 2022 with a period of performance through July 24, 2023. The contract is not associated with...
The Department of Health and Human Services, National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Speed Biosystems, LLC, a self-certified small disadvantaged and minority-owned business. The $146,600.00 contract is for the provision of TURBO293 transfection reagents, kits, protocols, and continuity support to aid coronavirus-related research at NIH labs and the Vaccine Research Center. The contract does...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Speed Biosystems, LLC, a minority-owned, small disadvantaged business, for the provision of TURBO293 transfection reagents, kits, protocols, and continuity support to aid coronavirus-related research at NIH labs and the Vaccine Research Center. The $146,600.00 contract was...

The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of TURBO293 transfection reagents. The $248,980.00 contract supports coronavirus-related research at NIH labs and the Vaccine Research Center. The award was sole-sourced to Speed Biosystems as the proprietary developer of the TURBO293 reagents, without any set-aside designation. Deliveries will take place at locations in Bethesda and Rockville, Maryland over a 15-month performance period ending on September 30, 2023.

Generated 3/23/24, 7:46 AM